Spectrum launched the company’s broad-based FUSILEV (levoleucovorin) marketing campaign directed towards oncologists, nurses, office practice managers and pharmacists. The recently launched campaign features a new FUSILEV.com website, health care professional educational tools and resources, digital and online campaign, and peer-to-peer live educational programs. All ZEVALIN (ibritumomab tiuxetan) Injection for Intravenous Use representatives will now also promote FUSILEV. This strategy will increase Spectrum’s FUSILEV dedicated sales resources by approximately 50% with no significant increase in operating expenses.
America has no tolerance for wealthy people griping about their financial woes. But they have concerns too.